Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ligand sequestration is a biophysical and pharmacological process by which ligands (including drugs, signaling molecules, or endogenous compounds) are captured or restricted within biological compartments such as lipid bilayers, vesicles, or other cellular structures, reducing their apparent concentration available for target binding[5]. This process can significantly affect the pharmacodynamics and pharmacokinetics of drugs or endogenous molecules by lowering the observable binding affinity, especially in in vivo systems relative to purified preparations. It does not refer to a discrete protein, receptor, or therapeutic target but is crucial for interpreting binding experiments and drug efficacy under physiologically relevant or complex system conditions[5].
Reduction of free ligand/drug concentration by sequestration in lipid membranes or other cellular compartments[5]. Alteration of effective drug concentration by compartmentalization, impacting pharmacokinetics[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ligand sequestration.